Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study-Reference-Cited by-同舟云学术

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study

Published:2020 Issue:5 Volume:5 Page:e000876
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Garrone Ornella^ORCID,Michelotti Andrea,Paccagnella Matteo,Montemurro Filippo^ORCID,Vandone Anna Maria,Abbona Andrea,Geuna Elena,Vanella Paola,De Angelis Claudia,Lo Nigro Cristiana,Falletta Antonella,Crosetto Nicola,Di Maio Massimo^ORCID,Merlano Marco^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response—the Neo-Runner study;ESMO Open;2024-08

2. Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients;British Journal of Cancer;2024-01-18

3. Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment;Cancers;2023-11-02

4. Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin;Breast Cancer Research and Treatment;2023-09-21

5. A joint profile of cytokines and immune cell populations may identify HNSCC patients who benefit from nivolumab treatment. The Gruppo Oncologico Nord-Ovest (GONO) study Nivactor T-2;2023-05-23